OFFICIAL USE ONI” lines so that there was a potential for a very useful exchange of information. Unfortunately, Dr. Kavanaugh died shortly after being named committee chairman and it will probably be necessary to start over. Dr. Totter suggested that the Advisory Committee might wish to comment on this problem in its letter to the chairman. Dr. Totter felt that a scientist with a good knowledge of the biomedical aspects of plutonium toxicity should be attached to the General Manager's office to coordinate all the plutonium activities within the Commission. The Division of Military Application apparently is being more cooperative with DBM than it has in the past, largely because of the very fine impression Dr. Richmond made while he was attached to the DBM staff. Dr. Totter reiterated his opinion that there is a strong need for better training programs for people who are going to work with plutonium. He feels that at the present time they are inadequately trained and are not sufficiently aware of the hazard. The committee then returned to the question of whether it would be advisable to have a carefully documented and well balanced article published on the plutonium problem. Dr. Finch thought that if a good article could be written, that Scientific American might be a good place to submit it. Members of the DBM staff at this point left the meeting and the committee considered its nominees for the Lawrence Award. Its final decision was that its first choices were Drs. Howard Adler from Oak Ridge and Dr. Marvin Goldman from the Davis Laboratory. The committee expressed no preference between these two. was the committee's third choice. Dr, Spar from the University of Rochester The Minutes of the 139th and 140th meetings were approved as distributed. The next meeting will be held at the Argonne National Laboratory on May 5-6, 1972. The committee adjourned at 11:45 A.M. Respectfully submitted, John B. Storer, M.D. Scientific Secretary Advisory Committee for Biology and Medicine OFFICIAL USE ONLY